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There has been an explosion of new knowledge in our
understanding of the biologic mechanisms of cardiovascular
disease. Over the past 30 years, the increase in the number
of clinical trials has risen exponentially. Today, new thera-
pies and sophisticated technologies are saving countless lives
and improving the functional status of millions of patients
with chronic heart disease. But, with medical science and
technology advancing at such a rapid pace, physicians are
overwhelmed with volumes of medical literature and uncer-
tainty about the effectiveness and appropriateness of alter-
native diagnostic and treatment strategies.
LACK OF TIME FOR LEARNING NEW KNOWLEDGE
To quote from the recently released Institute of Medicine
(IOM) report, Crossing the Quality Chasm (1), “Health care
today is characterized by more to know, more to manage,
more to watch, more to do, and more people involved in
doing it than at any other time in the nation’s history.”
Physicians are frustrated by limited time to keep up with,
and analyze, this huge amount of new medical knowledge.
Increasing patient workloads, caring for a more elderly and
sicker patient population, hours wasted writing redundant
information in paper charts and engagement in myriad
bureaucratic matters limit the time physicians can spend
with each of their patients and keep up with the medical
literature. They are finding it more difficult to devote the
necessary attention to learning and reviewing new and
revised evidence-based practice guidelines so that they can
effectively apply them to the everyday care of cardiac
patients.
Finding the time to stay current with new medical
knowledge and practice guidelines and to be trained in new
procedural techniques will become more and more difficult
in the future. Physicians are caring for an older and sicker
patient population with multiple chronic conditions. This
requires more physician time for every patient encounter.
The number of Americans with chronic diseases is expected
to grow to 134 million by 2020 (2). It is estimated that the
number of Americans 65 years or older will double to 78.5
million in the next 50 years (3). These increases will
contribute to a marked rise in the prevalence of coronary
heart disease (CHD) and heart failure (HF). Many of these
older patients will have complex, chronic cardiovascular
conditions that require careful and frequent surveillance and
management with multi-drug therapy and procedural inter-
ventions. A good contemporary example is Vice President
Cheney’s well-publicized clinical history of four myocardial
infarctions (MIs), a coronary bypass operation, a coronary
stenting procedure and a balloon angioplasty for in-stent
restenosis.
In addition, the epidemic of type 2 diabetes, fueled by
another epidemic of obesity and physical inactivity, will lead
to a striking increase in the number of young people in the
U.S. with CHD (4). For people in their 30s, the incidence
of diabetes rose nearly 70% from 1990 to 1998 (5). Diabetes
increases the risk of CHD two- to fourfold, and two-thirds
of diabetic patients will die of heart or blood vessel disease
(4). Thus, both the increase in the elderly population and an
increase in the number of young adults with cardiovascular
disease will demand that more of cardiovascular specialists’
time be devoted solely to clinical practice duties. There may
also be an emerging shortage in trained cardiologists,
compounding this demand for more practice activities.
Physicians here and overseas perceive that their ability to
provide quality care has declined. In a recent survey (6), 38%
to 59% of physicians replied that their ability to provide
quality care had diminished in the past five years. Of the
U.S. physicians surveyed, 56% felt that way. In this survey,
only 10% to 27% of the physicians in the five English-
speaking countries surveyed said that their ability to provide
quality care had improved. Almost three-quarters of the
physicians reported that if they could spend more time with
patients, the quality of care would improve (6).
ANTIQUATED MEDICAL INFORMATION SYSTEM
Physicians are working in an environment where informa-
tion technology is antiquated and the vast majority of
clinical information is still stored only on paper. Further-
more, as the IOM report pointed out (1), physician groups,
hospitals and other health care organizations operate as
individual “silos,” with each group rendering care without
the benefit of complete information about the patient’s
condition, prior medical history, services provided in other
settings and medications prescribed by other physicians.
Figure 1 depicts four hypothetical “silos” where medical care
is often provided to a patient with cardiac disease. It is not
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unusual for such a patient to have four independent medical
records housed in each “silo” of care with poor or no
communication among the providers working in these
settings. A separate IOM report (7) also indicated that
many medical errors, ubiquitous throughout the health care
system, could be prevented if clinical data were more easily
accessible and readable, and further, that the decentralized
and fragmented nature of the health care delivery system
“contributes to unsafe conditions for patients, and serves as
an impediment to efforts to improve safety. . . . Provision of
care to patients by a collection of loosely affiliated organi-
zations and providers makes it difficult to implement im-
proved clinical information systems capable of providing
timely access to complete patient information.”
All of these recent developments—information overload,
the increase in time pressures on physicians, the increased
prevalence of chronic heart disease, the growing complexity
of medical care and an increasingly fragmented and anti-
quated health care delivery system—together present a
challenge of colossal proportions. Because of these factors
and others, physicians are not providing high-quality car-
diovascular care to their patients in a uniform manner.
QUALITY OF CARE FOR PATIENTS WITH ACUTE MI
The treatment of patients with acute MI (AMI) is a perfect
example. Certain quality indicators describe the appropriate
process of care for patients with AMI. These indicators
include:
1) aspirin upon admission;
2) aspirin at discharge;
3) beta-blocker administration early during hospitalization;
4) maintenance beta-blocker therapy at discharge;
5) angiotensin-converting enzyme (ACE) inhibitors for
patients with a low ejection fraction (sometimes, ACE
inhibitors for all postinfarction patients);
6) assessment of lipid status;
7) use of statin therapy during hospitalization and continu-
ing after discharge; and
8) dietary, exercise and smoking cessation counseling.
Several years ago, Krumholz et al. (8) reported the rate of
beta-blocker use in patients 65 years of age or older who
survived hospitalization with AMI. More than 10 years after
the American College of Cardiology/American Heart As-
sociation (ACC/AHA) practice guidelines confirmed that
beta-blockers were highly effective in postinfarction pa-
tients, only 50% of patients without contraindications to
beta-blockers were given prescriptions for these drugs at
discharge. The report noted wide variation by state, from
30% to 77%. After adjustment for potential confounders,
those patients on beta-blockers showed a 14% lower mor-
tality one year after discharge. The National Registry of
Myocardial Infarction, which collected data on more than
167,000 patients nationwide, analyzed more recent data (9).
Figure 2 shows the percentage of patients receiving various
discharge medications that have a proven value for enhanc-
ing survival after AMI. Only 77% of the patients were
discharged with a prescription for aspirin, 65% with a
beta-blocker, 42% with an ACE inhibitor and 37% with a
statin drug. Only 42% of smokers received smoking cessa-
tion counseling. This report surveyed admissions from July
1999 to June 2000 and includes patients with no exclusions
for contraindications or intolerance to these drugs.
Great variability exists among medical centers in different
geographic regions of the U.S. regarding the percentage of
patients receiving beta-blockers at discharge for AMI. Data
in The Dartmouth Atlas of Cardiovascular Health Care (10)
show that compliance with the guideline of prescription of
beta-blockers at the time of hospital discharge ranged from
5% of “ideal” patients receiving such prescriptions to 92.5%
(Fig. 3). This variability was 10 times greater than rates of
compliance with the recommendation for aspirin. If the
ACC/AHA guidelines were more effectively and uniformly
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Figure 1. Four silos representing locales of care for a hypothetical patient
with cardiovascular disease. Presently, there is no common repository of
medical information for such a hypothetical patient that can be easily
accessed electronically by physicians or other hospital personnel in each of
these locales. Such inability to easily share medical information contributes
to overall lower quality care and increased chance for medical errors.
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applied to practice, the compliance rate would exceed 80%.
Jencks et al. (11) assessed the quality of medical care
delivered to Medicare beneficiaries on both the national and
state levels. The median performance was 72% with respect
to post-MI patients who were discharged with beta-
blockers. The state-by-state breakdown revealed wide vari-
ability, with 47% of the patients from Mississippi dis-
charged with beta-blockers after MI, compared with 93% in
Massachusetts.
Approximately 80,000 additional lives would be saved
each year in this country if we moved from actual use of
proven-effective therapy for patients with AMI to ideal use
(12). In this analysis, actual use of antiplatelet agents,
beta-blockers, ACE inhibitors and statins was estimated by
examining data from recent clinical trials involving patients
with MI. Ideal rates of use were derived from known or
suspected rates of true drug intolerance and from published
drug discontinuation rates in large clinical trials. For ACE
inhibitors, moving from a 50% actual-usage rate to 80% as
optimal use would save 30,600 lives per year. If beta-blocker
usage were increased only 10%, from 75% to the optimal use
of 85%, 12,600 lives would be saved. A total of 27,600 lives
would be saved if statin usage were increased from 50% to
70%. In a separate study, Phillips et al. (13) calculated the
cost-effectiveness of increased beta-blocker use among the
406,000 survivors of AMI in this country. If beta-blocker
use were increased over the next 10 years to ideal levels for
first-MI survivors, $18 million would be saved, 72,000 fewer
deaths would occur, 62,000 MIs would be prevented, and
447,000 life years would be gained.
The quality of care for AMI patients is also dependent on
physician specialty and the type of hospital to which a
patient is admitted. Figure 4 depicts the usage of aspirin,
heparin and beta-blockers in patients with AMI relative to
whether patients were cared for by cardiologists, internists
or general practice physicians (14). Note that for each
indicator, cardiologists performed better than primary care
physicians. Nevertheless, beta-blocker usage after AMI was
suboptimal for all three types of physicians surveyed. Nor-
cini et al. (15) evaluated the outcome of 30,000 AMI
patients relative to whether physicians treating those pa-
tients were certified or noncertified by the American Board
of Internal Medicine. The outcomes were analyzed relative
to whether cardiologists or primary care physicians treated
these patients. If board-certified doctors had treated all
30,000 AMI patients, 481 fewer in-hospital deaths would
Figure 2. Percentage of patients receiving various discharge medications
that have a proven value for enhancing survival after acute myocardial
infarction (MI). Note that only 65% of patients were discharged with a
beta-blocker, despite knowledge for more than 10 years that beta-blocker
therapy in post-MI patients reduces subsequent mortality. ACE 5
angiotensin-converting enzyme. ASA 5 aspirin.
Data from the National Registry of Myocardial Infarction-3, http://
www.med.ucla.edu/champ/NRMI.htm. Reprinted with permission from
Gregg C. Fonarow, MD.
Figure 3. Percentage of post-myocardial infarction (MI) patients receiving
beta-blockers at discharge in various geographic regions (each represented
by a solid circle) across the U.S. Note the marked variability in the
percentage of “ideal” patients receiving beta-blockers. If practice guidelines
were more effectively and uniformly applied to practice, this variability
would be far less, and more than 80% of all post-MI patients would be
receiving beta-blockers.
Copyright the Trustees of Dartmouth College 1999. Reprinted with
permission, from Wennberg DE, Birkmeyer JD. The Dartmouth Atlas of
Cardiovascular Health Care. Chicago, IL: The American Hospital Asso-
ciation Press, 1999 (10).
Figure 4. Usage of aspirin, heparin and beta-blockers in patients with AMI
relative to whether patients were cared for by cardiologists, internists or
general practice physicians.
Prepared, with acknowledgment of the authors, from data contained in
Jollis JG, DeLong ER, Peterson ED, et al. Outcome of acute myocardial
infarction according to the specialty of the admitting physician. N Engl
J Med 1996;335:1880–7 (14).
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have occurred. If cardiologists had treated all 30,000 pa-
tients, 802 fewer deaths would have been expected.
The use of ACE inhibitors and beta-blockers for patients
with AMI was analyzed relative to hospital teaching status
(16). Patients cared for in major teaching hospitals were
significantly more likely to receive ACE inhibitors and
beta-blockers compared with patients admitted to non-
teaching hospitals.
Insurance status appears to influence quality of cardiovas-
cular care. Patients who are uninsured are less likely to
undergo coronary arteriography or a percutaneous coronary
intervention after AMI compared with patients who have
commercial insurance or who are in the Medicare program
(17). Similarly, African Americans are less likely to undergo
optimal post-MI care and management of chronic coronary
artery disease (CAD) than white patients (18–20). For
example, in the study by Laouri et al. (19), 62.5% of African
Americans received “necessary revascularization” compared
with an 82.2% rate in white patients.
Thus, significant under-use of proven therapies for pa-
tients with AMI, and marked geographic variation in
adherence to recommended practice guidelines, are preva-
lent in our health care delivery system. Optimal adherence
to evidence-based practice guidelines for AMI is obviously
lacking.
QUALITY OF CARE FOR PATIENTS
WITH CONGESTIVE HEART FAILURE
Appropriate medication usage in patients with congestive
heart failure (CHF) is also suboptimal, as demonstrated in
several recent reports. Quality indicators for HF manage-
ment include: 1) appropriate use (or non-use) of ACE
inhibitors; 2) determination of left ventricular (LV) ejection
fraction for new-onset CHF; 3) appropriate use (or non-
use) of beta-blockers; and 4) appropriate discharge instruc-
tions, such as monitoring of weight, appropriate diet and
follow-up appointments. McCullough et al. (21) presented
the preliminary data of the Resource Utilization Among
Congestive Heart Failure, or REACH, study regarding
population-based medication profiling in HF patients at the
2000 Annual Scientific Session of the ACC. Within one
year of diagnosis of CHF, only 29% of these patients were
receiving treatment with beta-blockers, 49% with ACE
inhibitors, 4% with angiotensin-II receptor blockers, 4%
with hydralazine, 22% with nitrates, and 52% with one form
of vasodilator therapy. In the Medicare population, an
average of 69% of CHF patients were discharged with
prescriptions for ACE inhibitors (11). Wide variation from
state to state was observed.
Although the evaluation of LV function was documented
in 82.3% of CHF patients, practice-specific rates in a survey
of primary care and cardiology practices in 11 states (22)
ranged from 35% to 100%. The use of ACE inhibitors in
this study averaged 75.1% but varied between 0% and 100%.
Thus, significant performance gaps and appreciable
between-practice variation exist in LV function evaluation
and ACE inhibitor treatment of HF in the outpatient
setting. Another study (23), which surveyed four U.S.
health plans at six different geographic sites, revealed lack of
documentation of LV ejection fraction in 34% of CHF
patients. As with care for AMI patients, cardiologists used
ACE inhibitors more than noncardiologists in eligible
patients with documented LV dysfunction (24).
Quality of care for patients with CHF varies among types
of physicians. Both under-investigation and under-
treatment of elderly patients with CHF by family physi-
cians, compared with cardiologists, have been reported (25).
When managed by cardiologists, 92% of the patients with
CHF had an assessment of LV function when first present-
ing with HF, compared with 61% for family physicians.
Eighty percent of the HF patients were treated with ACE
inhibitors by cardiologists, compared with 60% by family
physicians (Fig. 5).
ADHERENCE TO LIPID MANAGEMENT GUIDELINES
A third area of concern, cholesterol management, also
shows gaps in quality care. Adherence to the National
Cholesterol Education Program (NCEP) guidelines for
cholesterol screening and lowering is suboptimal. Of 603
patients with cardiovascular disease treated at primary care
practices and surveyed by McBride et al. (26), 33% were not
screened with a lipid panel, 45% received no dietary coun-
seling, only 33% were receiving lipid-lowering medications,
and 14% had a low-density lipoprotein (LDL) cholesterol
,100 mg/dl. The National Committee for Quality Assur-
ance (NCQA) has been monitoring performance measures
related to LDL cholesterol levels in patients discharged after
MI, after bypass surgery or after undergoing a percutaneous
coronary intervention (27). As shown in Figure 6, an
average of only 45.3% of those patients with documented
Figure 5. Percentage of patients with congestive heart failure (HF) who
had documentation of a measurement of left ventricular function (LVF),
and the percentage use of angiotensin-converting enzyme (ACE) inhibitors
in HF patients, relative to whether cardiologists or family physicians were
responsible for their care. Note that cardiologists assessed LVF and used
ACE inhibitors more than noncardiologists in HF patients with depressed
LVF.
Prepared, with acknowledgment of the authors, from data contained in
Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary
care physicians and cardiologists in management of congestive heart failure:
relation to practice guidelines. J Am Coll Cardiol 1997;30:518–26 (25).
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CAD had an LDL cholesterol #130 mg/dl. Even the 90th
percentile of performance yielded only 64.4% of patients
achieving this target LDL level. It is likely that far fewer had
an LDL cholesterol level ,100 mg/dl, which should have
been the target goal. Cholesterol control for patients with
established CAD varies by region. The NCQA report
showed that Seattle fared the best in this benchmark,
whereas Dallas performed 20% lower, with only 37.3% of
appropriate patients achieving an LDL cholesterol of #130
mg/dl.
Patients with diabetes have a significantly greater mor-
bidity and mortality from CHD than nondiabetics, so it is
vitally important to lower abnormally elevated LDL cho-
lesterol levels in diabetic patients. The NCQA data from
2000 (27) indicate that lipid management is markedly
suboptimal in diabetics (Fig. 7). An average of only 36.7%
of diabetics had an LDL cholesterol #130 mg/dl. Surpris-
ingly, the 90th percentile achieved only a 48.5% lowering of
cholesterol to this level. Approximately 30% of diabetic
patients did not even have a lipid profile performed (27).
Patients without health insurance are less likely to un-
dergo cholesterol screening than patients who are insured.
Ayanian et al. (28) reported that 40.5% of adults uninsured
for one year or longer did not receive cholesterol screening
for CAD risk, compared with 18.1% who were insured. In
a report by Families USA (29), the question was asked,
“Have you ever had your blood cholesterol checked?”
Fifty-three percent of the insured answered in the affirma-
tive compared with only 23.2% of those uninsured. That
report also found that 43% of uninsured patients with
hyperlipidemia were no longer taking their prescribed med-
ications.
Adherence to NCEP guidelines in postmenopausal
women with heart disease was poor among the 2,763
women enrolled in the Heart and Estrogen/progestin Re-
placement Study, or HERS trial (30). While assessing the
effectiveness of hormone replacement therapy, this trial
determined that only 47% of the women were taking a
lipid-lowering medication. Sixty-three percent did not have
an LDL cholesterol ,130 mg/dl, and 91% did not have an
LDL cholesterol ,100 mg/dl, which is the target goal for
men and women with CHD.
Thus, as seen for post-MI care and evaluation and
management of CHF patients, quality of lipid disorders
management is suboptimal. Failure to appropriately lower
abnormally elevated LDL cholesterol levels in patients with
CHD or diabetes will contribute to an increased cardiovas-
cular mortality rate and increased prevalence of CHD.
ENHANCING THE
IMPLEMENTATION OF PRACTICE GUIDELINES
Numerous examples of under-treatment of MI and HF
patients have been shown. Examples of under-use of lipid
screening and under-treatment for elevated LDL choles-
terol management have been summarized. Having acknowl-
edged that such gaps in quality care exist, what can be done
to ensure that patients receive better care based on the best
available scientific knowledge? How can improved adher-
ence and more uniform implementation of the ACC/AHA
practice guidelines be achieved? How can the wide variation
in cardiovascular care in this country for patients with the
same cardiac disease be eliminated? Some progress in
finding answers to these questions regarding how quality of
cardiovascular care can be improved has already been made.
Certain medical groups such as the ACC and the AHA
have advocated the use of decision-support tools to improve
the implementation of practice guidelines in the inpatient
and outpatient settings. Such tools include standard pre-
printed orders, computer-generated reminders or verbal
reminders from nurses, pocket guidelines, clinical pathways
or algorithms of care, standardized patient discharge forms
Figure 6. Percentage of coronary artery disease (CAD) patients with either
previous myocardial infarction, prior bypass surgery or a percutaneous
coronary intervention who had a low-density lipoprotein (LDL) choles-
terol level #130 mg/dl. Note that even the 90th percentile of performance
in this survey yielded only 64.4% of patients achieving an LDL cholesterol
of #130 mg/dl. In actuality, the National Cholesterol Education Program
guidelines indicated that such patients with documented CAD need to
have their LDL cholesterol levels lowered to ,100 mg/dl.
Reprinted with permission from the National Committee for Quality
Assurance. The State of Managed Care Quality. 2000:23. r2000 by
NCQA (27).
Figure 7. Percentage of patients with diabetes who had a low-density
lipoprotein cholesterol of #130 mg/dl (left) and percentage of patients
with diabetes who had a lipid profile documented in their record (right).
Surprisingly, the 90th percentile in performance achieved only a 48.5%
lowering of cholesterol to this level in the diabetic population. An average
of only 69.1% of diabetics had a lipid profile even obtained. These data
from the National Committee for Quality Assurance indicate that lipid
management is markedly suboptimal in diabetics.
Reprinted with permission from the National Committee for Quality
Assurance. The State of Managed Care Quality Report. 2000:24. r2000 by
NCQA (27).
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and feedback on physician performance relative to prede-
termined quality indicators. Often, opinion leaders are
called upon to educate physicians regarding appropriate care
based on evidence-based practice guidelines. The increasing
tendency of patients to educate themselves is also an
important element in improving quality of care. Informed
patients work with their physicians to develop optimal
treatment plans for their specific medical conditions.
Use of such tools has yielded some recent improvement in
the care of patients with AMI. Figure 8 shows an increase
in beta-blocker treatment rates from 1996 to 1999 in
NCQA-accredited health plans, where quality indicators
are made public and health systems have an incentive to
improve (27). The rate of post-MI beta-blocker use in-
creased from 62.2% to 85% over this four-year period. Table
1 shows the quality improvement for post-MI care achieved
by the UCLA Cardiovascular Hospitalization Atheroscle-
rosis Management Program (CHAMP) (31). Using a vari-
ety of tools, CHAMP was able to achieve a substantial
increase in the utilization of aspirin, beta-blockers, ACE
inhibitors and statin drugs for post-MI patients. Usage of
ACE inhibitors increased from 4% to 56%, and statin usage
increased from 6% to 86%. Similar improvement in the
management of CHF has been achieved, primarily by
employing a multidisciplinary approach. Tools for HF care
include patient education, close monitoring of patients in
the outpatient and home settings, preprinted physician
order sets, chart audits with feedback of results, reminder
systems and use of local opinion leaders.
Another example of quality improvement is New York
State’s program of collecting standardized clinical data for
coronary bypass patients and releasing to the public the
risk-adjusted mortality rates for this procedure for hospitals
and individual surgeons (32,33). This program achieved a
lowering of the statewide mortality rate for bypass opera-
tions.
THE ACC AND QUALITY OF CARDIOVASCULAR CARE
The ACC has given priority to improving the quality of
cardiovascular care and encouraging better compliance with
clinical practice guidelines (34,35). The ACC launched a
major quality improvement initiative, the Guidelines Ap-
plied in Practice (GAP) Project (36). The goal of this
project was to see whether it is possible to improve adher-
ence to guidelines for treating AMI patients. Ten hospitals
in the greater Detroit area participated, with Dr. Kim Eagle
of the University of Michigan serving as the principal
investigator. The GAP team used a toolkit that included
pocket guides, standing orders, chart stickers, information
for patients, grand rounds presentations by opinion leaders
and reporting of hospital performance data. Results of the
GAP Project were presented at the College’s 2001 Annual
Scientific Session. Some of the quality indicators measured
were beta-blocker usage within 24 h, beta-blockers at
discharge, ACE inhibitors at discharge, aspirin at discharge,
smoking cessation counseling and cholesterol measurement
and treatment. A significant improvement in many of these
quality indicators was observed, particularly in the Medicare
population (e.g., early beta-blocker usage increased from
62% to 73%). Other GAP Projects are being planned,
including one for improving quality of care for patients with
CHF.
INTERNET-BASED ON-LINE LEARNING
More than decision-making tools are required to improve
the quality of cardiovascular care. Internet technology that
will allow physicians to access specific medical information in
any setting, at any time, using their computers or handheld,
wireless devices and sophisticated search engines that extract
this information from a rich database is being developed.
The ACC and the AHA are establishing an Internet website
that will enable physicians to do just that. It is presently known
as “KDE,” or the Knowledge Delivery Enterprise. Based on
advance Internet technology, KDE holds a key to increased
guideline use. It will permit physicians to obtain information at
Figure 8. Improvement in treatment rates for beta-blocker therapy and
post-myocardial infarction (MI) patients from 1996 to 1999 in National
Committee for Quality Assurance-accredited health plans, where quality
indicators are made public and health systems have an incentive to improve.
Note that the rate of post-MI beta-blocker use increased from 62.2% to
85% over this four-year period.
Reprinted with permission from the National Committee for Quality
Assurance. The State of Managed Care Quality Report. 2000:30. r2000 by
NCQA (27).
Table 1. Hospital-Based Congestive Heart Failure Treatment
Programs: The UCLA-CHAMP Experience
Coronary Artery Disease
Treatment Rates
1992 to 1993
(n 5 256)
1994 to 1995
(n 5 302)
Hospital discharge
Aspirin 78% 92%
Beta-blocker 12% 61%
ACE inhibitor 4% 56%
Statin 6% 86%
ACE 5 angiotensin-converting enzyme; CHAMP 5 Cardiovascular Hospitalization
Atherosclerosis Management Program; UCLA 5 University of California-Los
Angeles.
Reprinted, as adapted, from Am J Cardiol, vol. 85, Fonarow GC and Gawlinski
A, Rationale and design of the Cardiac Hospitalization Atherosclerosis Management
Program at the University of California Los Angeles, pages 10A–17A, Copyright
2000, with permission from Excerpta Medica Inc.
592 Beller JACC Vol. 38, No. 3, 2001
Presidential Address September 2001:587–94
the point of care to help guide them with their decision-
making for specific patient problems.
The dissemination of computer technology into physician
offices with greater use of desktop computers and more
Internet access to medical information websites has facili-
tated more rapid delivery of new scientific information and
medical knowledge as well as providing self-learning pro-
grams for which continuing medical education (CME)
credit is given. The KDE system will be robust in this
regard.
Didactic teaching in the form of lectures is not that
effective in changing physician performance (37). Interactive
CME sessions that require active participation of the learner
are more effective in changing outcomes. Such interactive
learning models are presently available from many Internet
websites. The electronic delivery of CME in the form of
case-based learning using multimedia technology should
prove a more effective way of disseminating the application
of practice guidelines. We hope that this type of on-line
education will translate into greater quality and less varia-
tion in cardiovascular care.
ADVANCED INFORMATION TECHNOLOGY AND THE
ELECTRONIC MEDICAL RECORD
Once greater and easier access to more medical knowledge
through advanced computer technology is attained, new
technology for sharing patient information among caregiv-
ers must also be developed. To do this, a cultural shift in the
everyday use of information technology in physicians’ offices
and hospitals must occur. Far too much patient information
is stored only on paper. The space industry has integrated its
technology systems to send a space ship to an asteroid 117
million miles from Earth (38), but the medical profession is
still documenting its patient information in numerous charts
stored in different health care settings with no technological
linkages among them. We must move to electronic medical
records. Automating clinical data will improve coordination
of care across the various venues where health care is
delivered. We should no longer hear, “We can’t find the old
chart,” and we should no longer treat patients without the
full knowledge of their previous and concurrent treatment
by other health care providers.
In their outpatient practices and the hospitals where they
work, cardiologists must advocate the use of new technology
to integrate the care their patients receive across the various
settings, or “silos,” where patients are seen (Fig. 1). There
should be a single electronic repository of medical data for each
patient that can be accessed by all that patient’s physicians,
wherever they may be.
CONCLUSION: THE NEED FOR AN
ELECTRONIC REVOLUTION IN HEALTH CARE
The ACC is committed to closing the gap between average
care and best care for cardiologic conditions in the U.S. for
all Americans. The College is applying the talents of its
members and its staff to making scientific medical knowl-
edge more accessible and useful to clinicians and patients.
Web-based decision-support tools, like KDE, will assist
doctors and patients in approving the quality of cardiac care.
No matter how successful we might be in obtaining state-
of-the-art knowledge where we need it from a system like
KDE, cardiac care will never be optimal until we also
transform, via new technology, our health care delivery
system. The members of the College are encouraged to
work in their own communities to implement the informa-
tion technology needed to better use scientific knowledge in
an efficient and coordinated manner across all settings of
care. We need an electronic revolution in medicine to meet
the challenges of the future.
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